• News & Events
  • Resources
  • Careers
  • Investors
Aptar Logo
  • Products
  • business areas
  • Services
  • ESG
  • About Aptar
Pharmaceutical, Webinars

Introducing PureHale® for Targeted Upper Respiratory Tract Care

16 Sep 2021

Aptar Pharma’s PureHale® Technology Platform is the industry’s first portable, ready-to-use, nebulizer-like system that dispenses a continuous fine mist that targets the nasal cavity, throat and pharynx. When used in combination with saline or other natural ingredient formulations, PureHale® may help to prevent or relieve symptoms of upper respiratory tract conditions such as coughs and colds, allergies, dry nose or throat, and other irritations.

September 16, 2021
3:30 PM London / 10:30 AM New York 
1 Hour

Share
Thumbnail_Webinar_PureHaleDeposition2021.jpg